Premium
Brain Angiotensin II, an Important Stress Hormone: Regulatory Sites and Therapeutic Opportunities
Author(s) -
SAAVEDRA J M.,
ANDO H,
ARMANDO I,
BAIARDI G,
BREGONZIO C,
JEZOVA M,
ZHOU J
Publication year - 2004
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1296.009
Subject(s) - endocrinology , receptor , medicine , hypothalamus , stimulation , angiotensin ii , median eminence , subfornical organ , hormone , receptor antagonist , chemistry , antagonist
A bstract : The presence of a brain Angiotensin II (Ang II) system, separated from and physiologically integrated with the peripheral, circulating renin‐angiotensin system, is firmly established. Ang II is made in the brain and activates specific brain AT 1 receptors to regulate thirst and fluid metabolism. Some AT 1 receptors are located outside the blood‐brain barrier and are sensitive to brain and circulating Ang II. Other AT 1 receptors, located inside the blood‐brain barrier, respond to stimulation by Ang II of brain origin. AT 1 receptors in the subfornical organ, the hypothalamic paraventricular nucleus (PVN), and the median eminence are involved in the regulation of the stress response. In particular, AT 1 receptors in the PVN are under glucocorticoid control and regulate corticotrophin‐releasing hormone (CRH) formation and release. In the PVN, restraint elicits a fast increase in AT 1 receptor mRNA expression. The expression of paraventricular AT 1 receptors is increased during repeated restraint and after 24 h of isolation stress, and their stimulation is essential for the hypothalamic‐pituitary‐adrenal axis activation, the hallmark of the stress response. Peripheral administration of an AT 1 receptor antagonist blocks peripheral and brain AT 1 receptors, prevents the sympathoadrenal and hormonal response to isolation stress, and prevents the gastric stress ulcers that are a characteristic consequence of cold‐restraint stress. This evidence indicates that pharmacologic inhibition of the peripheral and brain Ang II system by AT 1 receptor blockade has a place in the prevention and treatment of stress‐related disorders.